| John Doyle Bailey, MD | |
|
2525 Telephone Rd, Pascagoula, MS 39567 | |
| (228) 762-4483 | |
| (228) 769-0406 |
| Full Name | John Doyle Bailey |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 33 Years |
| Location | 2525 Telephone Rd, Pascagoula, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427063791 | NPI | - | NPPES |
| 020041900 | Other | MS | RR MEDICARE |
| 00117625 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 14781 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Singing River Health System | Pascagoula, MS | Hospital |
| Garden Park Medical Center | Gulfport, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Singing River Health System | 3870405194 | 156 |
News Archive
The former president - dubbed the "explainer in chief" - spoke from his presidential library in Arkansas to drum up support for the overhaul and scold Republicans for their efforts to repeal it.
Rice University physicists have written the next chapter in an innovative approach for studying the forces that shape proteins - the biochemical workhorses of all living things.
A rare malignancy known as squamous cell carcinoma of the anal canal (SCCA) is on the increase, and now researchers have reported results of the first-ever phase II clinical trial results for treatment with the immunotherapy drug nivolumab.
A new study has come down solidly on the side of routine screening mammograms as a preventative measure in the fight against cancer.
AstraZeneca today announced plans to conduct the EUCLID study, a global clinical trial involving 11,500 patients with peripheral artery disease (PAD), a condition affecting approximately 27 million people in Europe and North America.
› Verified 5 days ago
| Entity Name | Singing River Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083893937 PECOS PAC ID: 3870405194 Enrollment ID: O20031104000435 |
News Archive
The former president - dubbed the "explainer in chief" - spoke from his presidential library in Arkansas to drum up support for the overhaul and scold Republicans for their efforts to repeal it.
Rice University physicists have written the next chapter in an innovative approach for studying the forces that shape proteins - the biochemical workhorses of all living things.
A rare malignancy known as squamous cell carcinoma of the anal canal (SCCA) is on the increase, and now researchers have reported results of the first-ever phase II clinical trial results for treatment with the immunotherapy drug nivolumab.
A new study has come down solidly on the side of routine screening mammograms as a preventative measure in the fight against cancer.
AstraZeneca today announced plans to conduct the EUCLID study, a global clinical trial involving 11,500 patients with peripheral artery disease (PAD), a condition affecting approximately 27 million people in Europe and North America.
› Verified 5 days ago
| Entity Name | South Mississippi Surgeons |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598776627 PECOS PAC ID: 9032198155 Enrollment ID: O20040714000349 |
News Archive
The former president - dubbed the "explainer in chief" - spoke from his presidential library in Arkansas to drum up support for the overhaul and scold Republicans for their efforts to repeal it.
Rice University physicists have written the next chapter in an innovative approach for studying the forces that shape proteins - the biochemical workhorses of all living things.
A rare malignancy known as squamous cell carcinoma of the anal canal (SCCA) is on the increase, and now researchers have reported results of the first-ever phase II clinical trial results for treatment with the immunotherapy drug nivolumab.
A new study has come down solidly on the side of routine screening mammograms as a preventative measure in the fight against cancer.
AstraZeneca today announced plans to conduct the EUCLID study, a global clinical trial involving 11,500 patients with peripheral artery disease (PAD), a condition affecting approximately 27 million people in Europe and North America.
› Verified 5 days ago
| Entity Name | Singing River Gulfport |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861010159 PECOS PAC ID: 5294154829 Enrollment ID: O20201001001497 |
News Archive
The former president - dubbed the "explainer in chief" - spoke from his presidential library in Arkansas to drum up support for the overhaul and scold Republicans for their efforts to repeal it.
Rice University physicists have written the next chapter in an innovative approach for studying the forces that shape proteins - the biochemical workhorses of all living things.
A rare malignancy known as squamous cell carcinoma of the anal canal (SCCA) is on the increase, and now researchers have reported results of the first-ever phase II clinical trial results for treatment with the immunotherapy drug nivolumab.
A new study has come down solidly on the side of routine screening mammograms as a preventative measure in the fight against cancer.
AstraZeneca today announced plans to conduct the EUCLID study, a global clinical trial involving 11,500 patients with peripheral artery disease (PAD), a condition affecting approximately 27 million people in Europe and North America.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Doyle Bailey, MD 2525 Telephone Rd, Pascagoula, MS 39567 Ph: (228) 762-4483 | John Doyle Bailey, MD 2525 Telephone Rd, Pascagoula, MS 39567 Ph: (228) 762-4483 |
News Archive
The former president - dubbed the "explainer in chief" - spoke from his presidential library in Arkansas to drum up support for the overhaul and scold Republicans for their efforts to repeal it.
Rice University physicists have written the next chapter in an innovative approach for studying the forces that shape proteins - the biochemical workhorses of all living things.
A rare malignancy known as squamous cell carcinoma of the anal canal (SCCA) is on the increase, and now researchers have reported results of the first-ever phase II clinical trial results for treatment with the immunotherapy drug nivolumab.
A new study has come down solidly on the side of routine screening mammograms as a preventative measure in the fight against cancer.
AstraZeneca today announced plans to conduct the EUCLID study, a global clinical trial involving 11,500 patients with peripheral artery disease (PAD), a condition affecting approximately 27 million people in Europe and North America.
› Verified 5 days ago
David Lamar Spencer Sr., MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2525 Telephone Rd, Pascagoula, MS 39567 Phone: 228-762-4483 Fax: 228-769-0406 | |
Nicholas John Fayard, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2525 Telephone Rd, Pascagoula, MS 39567 Phone: 228-762-4483 Fax: 228-762-3147 | |
Dr. David Milton Jenkins, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2525 Telephone Rd, Pascagoula, MS 39567 Phone: 228-762-4483 Fax: 228-769-0406 | |
William Travis Avara Iii, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2525 Telephone Rd, Pascagoula, MS 39567 Phone: 228-762-4483 Fax: 228-769-0406 | |
Dr. Ramon A.g. Brown, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3101 Denny Ave Ste 200, Pascagoula, MS 39581 Phone: 228-471-1476 | |
Jason Payne, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2525 Telephone Rd, Pascagoula, MS 39567 Phone: 228-762-4483 Fax: 228-769-0406 |